Tenax Therapeutics, Inc. · NASDAQ:TENX
Giordano Christopher Thomas bought 10,850 Tenax Therapeutics, Inc. shares (Form 4)
Traded Sep 11 to Sep 15, 2026 · Filed Sep 15, 2026
From Sep 11 to Sep 15, 2026, Giordano Christopher Thomas (Director, CEO) bought 10,850 Tenax Therapeutics, Inc. shares at an average US$1.85 for US$20,107, leaving 22,174 shares. Filed Sep 15, 2026 (Form 4).
- Bought
- 10,850 shares
- Price
- US$1.85 average (US$1.82 to US$1.88)
- Value
- US$20,107
- Holding after
- 22,174 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Buy | 6,000 | US$1.88 | 17,324 | Direct |
| Sep 15, 2026 | Common Stock | Buy | 4,850 | US$1.82 | 22,174 | Direct |
Source
Related
- Tenax Therapeutics, Inc.
- Giordano Christopher Thomas
- Tenax Therapeutics, Inc. shareholders
- Form 4 · Giordano Christopher Thomas · Jul 14, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026